申请人:Novartis AG
公开号:US20210323947A1
公开(公告)日:2021-10-21
The invention provides compounds of Formula (I):
as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections.
这项发明提供了如下式(I)的化合物:
如本文所述,以及包含这些化合物的药用盐、含有这些化合物的药物组合物,以及治疗病毒感染的方法。